These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 2763513)

  • 1. [Effect of immunosuppression on the development and outcome of an acute infection in mice caused by administration of the Lassa virus].
    Barkar ND; Mar'iankova RF; Godneva AT; Grigor'eva LV; Zudin BI
    Vopr Virusol; 1989; 34(2):208-13. PubMed ID: 2763513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Lassa and Mozambique viruses: cross protection in experiments on mice and action of immunosuppressants on experimental infections].
    Barkar ND; Lukashevich IS
    Vopr Virusol; 1989; 34(5):598-603. PubMed ID: 2609647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experimental Lassa fever in hamadryas baboons].
    Evseev AA; Dvoretskaia VI; Bogatikov GV; Pshenichnov VA; Mustafin RM
    Vopr Virusol; 1991; 36(2):150-2. PubMed ID: 1882523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunogenic and protective characteristics of recombinant Lassa virus NP protein].
    Ignat'ev GM
    Vopr Virusol; 2002; 47(2):28-31. PubMed ID: 12046464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lassa fever virus: properties and characteristics.
    Tomori O; Fabiyi A
    Niger Med J; 1979 Jan; 9(1):17-9. PubMed ID: 111436
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pathogenicity of the Lassa virus for laboratory mice].
    Lukashevich IS; Orlova SV; Mar'iankova RF; Barkar ND
    Vopr Virusol; 1985; 30(5):595-9. PubMed ID: 4072162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Acute and chronic Lassa virus infection of Vero cells].
    Lukashevich IS; Mar'iankova RF; Fidarov FM
    Vopr Virusol; 1981; (4):452-6. PubMed ID: 7303630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lassa virus.
    Günther S; Lenz O
    Crit Rev Clin Lab Sci; 2004; 41(4):339-90. PubMed ID: 15487592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A live attenuated vaccine for Lassa fever made by reassortment of Lassa and Mopeia viruses.
    Lukashevich IS; Patterson J; Carrion R; Moshkoff D; Ticer A; Zapata J; Brasky K; Geiger R; Hubbard GB; Bryant J; Salvato MS
    J Virol; 2005 Nov; 79(22):13934-42. PubMed ID: 16254329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [An update on Lassa virus].
    Leparc-Goffart I; Emonet SF
    Med Trop (Mars); 2011 Dec; 71(6):541-5. PubMed ID: 22393616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A trial to produce an inactivated Lassa fever vaccine].
    Krasnianskiĭ VP; Potryvaeva NV; Borisevich IV; Gradoboev VN; Pashanina TP; Pshenichnov VA
    Vopr Virusol; 1993; 38(6):276-9. PubMed ID: 8303891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The tragic story of the discovery of the Lassa fever virus].
    Muggia A
    Minerva Med; 1970 Mar; (26 Suppl):16. PubMed ID: 5498893
    [No Abstract]   [Full Text] [Related]  

  • 13. Experimental infection of rhesus monkeys with Lassa virus and a closely related arenavirus, Mozambique virus.
    Walker DH; Johnson KM; Lange JV; Gardner JJ; Kiley MP; McCormick JB
    J Infect Dis; 1982 Sep; 146(3):360-8. PubMed ID: 6286795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zidampidine, an aryl phosphate derivative of AZT: in vivo pharmacokinetics, metabolism, toxicity, and anti-viral efficacy against hemorrhagic fever caused by Lassa virus.
    Uckun FM; Venkatachalam TK; Erbeck D; Chen CL; Petkevich AS; Vassilev A
    Bioorg Med Chem; 2005 May; 13(9):3279-88. PubMed ID: 15809163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a new vaccine for the prevention of Lassa fever.
    Geisbert TW; Jones S; Fritz EA; Shurtleff AC; Geisbert JB; Liebscher R; Grolla A; Ströher U; Fernando L; Daddario KM; Guttieri MC; Mothé BR; Larsen T; Hensley LE; Jahrling PB; Feldmann H
    PLoS Med; 2005 Jun; 2(6):e183. PubMed ID: 15971954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Broad-spectrum antiviral activity of small interfering RNA targeting the conserved RNA termini of Lassa virus.
    Müller S; Günther S
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2215-8. PubMed ID: 17371814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Case of Human Lassa Virus Infection With Robust Acute T-Cell Activation and Long-Term Virus-Specific T-Cell Responses.
    McElroy AK; Akondy RS; Harmon JR; Ellebedy AH; Cannon D; Klena JD; Sidney J; Sette A; Mehta AK; Kraft CS; Lyon MG; Varkey JB; Ribner BS; Nichol ST; Spiropoulou CF
    J Infect Dis; 2017 Jun; 215(12):1862-1872. PubMed ID: 28863472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study of certain indicators of immunity upon infecting CBA/Calac line mice with Lassa virus].
    Ignat'ev GM; Kaliberov SA; Pereboeva LA; Tverdokhlebov AB; Kras'ko AG; Godneva AT
    Vopr Virusol; 1994; 39(6):257-60. PubMed ID: 7536373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical virology of Lassa fever in hospitalized patients.
    Johnson KM; McCormick JB; Webb PA; Smith ES; Elliott LH; King IJ
    J Infect Dis; 1987 Mar; 155(3):456-64. PubMed ID: 3805773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lassa fever encephalopathy: clinical and laboratory findings.
    Cummins D; Bennett D; Fisher-Hoch SP; Farrar B; Machin SJ; McCormick JB
    J Trop Med Hyg; 1992 Jun; 95(3):197-201. PubMed ID: 1597876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.